Rosa Torres Blanch
About Rosa Torres Blanch
Rosa Torres Blanch is a CAR-T Medical Science Liaison at Bristol Myers Squibb with extensive experience in immuno-hemato-oncology and cell therapy.
Current Position at Bristol Myers Squibb
Rosa Torres Blanch currently holds the position of CAR-T Medical Science Liaison (MSL) at Bristol Myers Squibb. She started her tenure on January 1, 2021. Her role in the company involves focusing on CAR-T cell therapy, a cutting-edge area in oncology, reflecting her strong enthusiasm for cell therapy and extensive background in the field.
Previous Experience at Celgene
Prior to joining Bristol Myers Squibb, Rosa Torres Blanch worked at Celgene. She served as a Medical Science Liaison (MSL) focusing on hematology, including lymphoma and cell therapy, from 2018 to 2020. Her two-year tenure at Celgene allowed her to deepen her expertise in hematologic malignancies and advanced therapies.
Scientific Leadership at Merck Group
Rosa Torres Blanch's career also includes significant roles at the Merck Group. She served as the Scientific Lead in Immuno-Oncology for nine months in 2018, and as a Medical Scientific Liaison (MSL) in Immuno-Oncology/Oncology from 2016 to 2017. These positions underscore her extensive experience in scientific leadership and medical liaison roles within the oncology sector.
Academic and Research Background
Rosa Torres Blanch has a strong academic and research background. She studied at Universitat Autònoma de Barcelona, earning a Ph.D. in Immunopharmacology and a Master's Degree in Immunology. She also obtained a Master's Degree in Biotechnology and a Bachelor's Degree in Biological Sciences from Universitat de Barcelona. Additionally, she has completed specialized training and held research positions at Harvard Medical School, Stanford University School of Medicine, and Vall d’Hebron Institute of Research (VHIR).
Experience at LEITAT Technological Center
In 2015, Rosa Torres Blanch worked as the Principal Researcher in Efficacy and Safety at the Bioinvitro Unit, S&S of the LEITAT Technological Center. This role, based at Parc Científic de Barcelona, involved leading research projects focused on evaluating the efficacy and safety of various biotechnological products.